Powerful anti-psychotic drug Risperdal has been widely used to treat conditions ranging from schizophrenia to dementia. Unfortunately, serious side effects have also been linked to use of this drug. One such known risk is stroke, which is especially prevalent in elderly patients using Risperdal for dementia treatment. Sadly, the U.S. Department of Justice accused Janssen Pharmaceuticals of knowing of these risks and intentionally concealing them while continuing to market the drug—despite the known risks. Prosecutors allege that the company knew of the increased risk of stroke in elderly dementia patients as early as 2003. The results of the associated study were not published for several years, during which time the company provided only limited data to customers and consumers that made the risk of adverse side effects linked to the drug appear far lower.
Complications Associated With a Stroke Following Risperdal Use
A stroke occurs when the flow of oxygenated blood to the brain is cut off. This condition constitutes a medical emergency that can lead to severe injury and even death. There are two main types of stroke: Hemorrhagic stroke, which involves bleeding in the brain, and ischemic stroke, which involves blood clots in the brain. Studies have linked Risperdal use with stroke, including mini-strokes, also known as transient ischemic attacks. These mini-strokes occur when a blood clot cuts off blood flow to the brain for approximately five minutes or less. If blood flow is not restored quickly, brain cells begin to die and the patient will experience brain damage. Risperdal users who suffered stroke may find themselves suffering from significant ongoing complications, including the following:
- Muscle weakness
- Speech problems
- Intellectual disability
- Memory loss
- Organ damage
Patients who have taken Risperdal and experienced adverse side effects may have a claim for compensation. To learn more, we encourage you to contact us today at 888-526-7616.